MetaCap

LeMaitre Vascular Financial Ratios

NASDAQ: LMATHealth CareMedical/Dental InstrumentsUSD

80.69+1.05 (+1.32%)

At close: Oct 9, 4:00 PM ET · Delayed 15 min

LeMaitre Vascular ratio analysis

LeMaitre Vascular earned a net margin of 23.1% in FY 2025, up from 20.0% a year earlier. Gross margin was 71.5% compared with a median of 68.1% over the prior 9 years. Return on equity reached 14.7%, meaning LeMaitre Vascular generated 0.15 dollars of profit for every dollar of shareholders' equity.

At the end of FY 2025, LMAT traded at 31.8 times earnings; across the 10 fiscal years shown, its year-end P/E ranged from 20.4 to 49.5, with a median of 40.7. Valuation ratios use the closing share price on each fiscal year-end date and diluted shares from the income statement; profitability and leverage ratios use reported annual figures. Current valuation multiples are on the statistics page.

Summary generated from market data by MetaCap's automated system. Methodology

LeMaitre Vascular financial ratios (annual)

LeMaitre Vascular annual financial ratios
RatioFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
P/E ratio (at fiscal year end)31.8147.5342.3649.4840.1838.9441.1320.3637.0246.07
Price / sales7.279.376.526.266.886.346.124.235.995.25
Price / book4.616.114.233.774.184.754.843.435.505.35
Gross margin71.5%68.6%65.7%64.9%65.7%65.4%68.1%70.0%70.1%70.6%
Operating margin27.2%23.8%19.0%16.6%23.6%22.3%18.1%26.7%20.9%18.3%
Net margin23.1%20.0%15.6%12.8%17.4%16.4%15.3%21.7%17.0%11.9%
Free cash flow margin29.8%16.9%15.2%13.7%19.6%24.6%8.9%15.6%16.3%15.8%
Return on equity (ROE)14.7%13.1%10.1%7.7%10.6%12.3%12.1%17.6%15.6%12.1%
Return on assets (ROA)9.4%8.0%8.7%6.6%9.2%8.4%9.5%15.0%13.6%10.4%
Current ratio12.8913.146.516.396.413.754.424.766.095.63
Revenue growth13.5%13.6%19.7%4.7%19.4%10.4%11.0%4.7%13.1%13.8%
EPS growth30.6%44.0%44.1%-25.6%20.2%18.2%-22.1%31.4%56.4%31.0%

Related